Cargando…
Combating challenges in CAR-T cells with engineering immunology
Chimeric antigen receptors (CAR) T cells (CAR-T) mark a significant step towards producing safe and effective personal anticancer treatments. CAR-T strategies engineers the T cells from the patients to allow specific binding to a tumour-specific antigen. CAR-Ts are a second-wave offensive strategy t...
Autores principales: | Wang, Clement Yisai, Ting Cheung, Stephanie Po, Sugimura, Ryohichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589253/ https://www.ncbi.nlm.nih.gov/pubmed/36299480 http://dx.doi.org/10.3389/fcell.2022.969020 |
Ejemplares similares
-
The Role of Innate Lymphoid Cells in Cancer Development and Immunotherapy
por: Sugimura, Rio, et al.
Publicado: (2022) -
Deciphering Innate Immune Cell-Tumor Microenvironment Crosstalk at a Single-Cell Level
por: Sugimura, Ryohichi, et al.
Publicado: (2022) -
Immune-epigenetic crosstalk in haematological malignancies
por: Wong, Hera, et al.
Publicado: (2023) -
Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges
por: Wang, Shihua H., et al.
Publicado: (2021) -
Mechanisms of CAR T cell exhaustion and current counteraction strategies
por: Zhu, Xiaoying, et al.
Publicado: (2022)